ruxolitinib
UkraineDrugs containing this active substance
-
The drug is used to treat adults with myelofibrosis (specifically with splenomegaly or disease symptoms), polycythemia vera (if other medicines are not suitable), and for the treatment of acute or chronic graft-versus-host disease in patients aged 12 years and older.
Form: tablets
Active substance Dosage ruxolitinib 5 mg ATC: L01EJ01
Manufacturer: Novartis Pharma Stein AG (manufacturing, quality control, primary and secondary packaging, batch release)
-
The drug is used to treat adults with myelofibrosis (specifically with splenomegaly or disease symptoms), polycythemia vera (if other medicines are unsuitable), and for the treatment of acute or chronic graft-versus-host disease in patients aged 12 years and older.
Form: tablets
Active substance Dosage ruxolitinib 15 mg ATC: L01EJ01
Manufacturer: Novartis Pharma Stein AG (manufacturing, quality control, primary and secondary packaging, batch release)
-
The drug is used to treat adults with myelofibrosis (particularly associated with splenomegaly), polycythemia vera (if other medicines are unsuitable), and for the treatment of acute or chronic graft-versus-host disease in patients aged 12 years and older.
Form: tablets
Active substance Dosage ruxolitinib 20 mg ATC: L01EJ01
Manufacturer: Novartis Pharma Stein AG (manufacturing, quality control, primary and secondary packaging, batch release)